Results 201 to 210 of about 1,708,072 (297)

Modeling dose to normal brain following hypofractionated stereotactic radiotherapy to a single brain metastasis. [PDF]

J Appl Clin Med Phys
Johns E, Hargrave C, Nissen L, Barry TJ, Bernard A, Pinkham MB.   +5 more
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Focus on Allied Health Professionals announcement: Introducing practice change initiative reports for the Focus on Allied Health Professionals section. [PDF]

HeartRhythm Case Rep
Ross HM.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Australian clinical guideline for deprescribing in older people. [PDF]

Aust Prescr
europepmc   +1 more source

Comment on published article "A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale". [PDF]

Indian Dermatol Online J
Gupta A, Neema S.
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Novel pencil-beam scanning proton lattice radiation therapy for the treatment of bulky liver cancer: dosimetric comparison with VMAT-lattice radiotherapy. [PDF]

Front Oncol
Li Y, Martin-Paulpeter RM, Chung CV, Aguilar MA, Matias CA, Delgado A, Nair SS, Court LE, Perles L, Sahoo N, Zhu RX, Poenisch F, Flint DB, Sawakuchi GO, Beddar S, Koay E, Baker JS, Ludmir EB, Niedzielski JS.   +18 more
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Stakeholder-based assessment of historical urban landscapes as cultural heritage within the context of sustainable development: a case study of İznik (Nikaia). [PDF]

Sci Rep
Kapuci U, Cengiz C, Smardon RC, Cengiz B.   +3 more
europepmc   +1 more source